Key Takeaways
- The time for Ionis Pharmaceuticals’ Q4 2025 financial results webcast has been moved to 8:30 a.m. ET on February 25.
- The original date remains the same, with the live stream accessible online.
- Ionis Pharmaceuticals focuses on innovative RNA-targeted therapies for serious diseases.
Webcast Time Change Announcement
Ionis Pharmaceuticals, Inc. has announced a change in the timing for its upcoming webcast concerning the fourth quarter and full year 2025 financial results. The live presentation was initially set for 11:30 a.m. Eastern Time but will now take place at 8:30 a.m. Eastern Time on Wednesday, February 25, while the date of the event remains unchanged.
Investors and interested parties can access the webcast through the Ionis investor relations page at https://ir.ionis.com/events-and-presentations/upcoming-events. A recording of the presentation will be available for a limited time at the same link.
About Ionis Pharmaceuticals, Inc.
Established for over 30 years, Ionis Pharmaceuticals focuses on creating innovative therapies to improve the lives of patients with serious diseases. The company boasts a marketed portfolio and a strong pipeline, particularly in neurology and cardiometabolic diseases, in addition to addressing high patient needs. Ionis is recognized as a leader in RNA-targeted medicines and is committed to advancing gene editing initiatives.
The company’s deep understanding of disease biology, paired with its cutting-edge technology, drives its mission to deliver impactful advancements in patient care. For further information about Ionis, please visit Ionis.com or follow the company on social media platforms such as X (Twitter), LinkedIn, and Instagram.
Investor and Media Contacts
For investor inquiries, contact D. Wade Walke, Ph.D. at IR@ionis.com or call 760-603-2331. For media requests, reach Hayley Soffer at media@ionis.com or call 760-603-4679.
The content above is a summary. For more details, see the source article.
